Meta-analysis of first-line therapies with maintenance regimens for advanced non-small-cell lung cancer (NSCLC) in molecularly and clinically selected populations

10.1002/cam4.1101

Saved in:

Bibliographic Details
Main Authors:	Tan, P.S, Bilger, M, Lopes, G.L, Acharyya, S, Haaland, B
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Article
Published:	2020
Subjects:	afatinib antineoplastic agent bevacizumab cetuximab conatumumab epidermal growth factor receptor erlotinib gefitinib necitumumab pemetrexed tumor marker Article cancer combination chemotherapy cancer survival drug efficacy EGFR gene gene gene mutation histology human meta analysis non small cell lung cancer outcome assessment overall survival patient selection personalized medicine priority journal progression free survival squamous cell lung carcinoma survival analysis survival rate survival time Bayes theorem cancer staging genetics induction chemotherapy lung tumor maintenance chemotherapy metastasis mortality mutation prognosis proto oncogene treatment outcome Antineoplastic Combined Chemotherapy Protocols Bayes Theorem Biomarkers, Tumor Carcinoma, Non-Small-Cell Lung Genes, erbB-1 Humans Induction Chemotherapy Lung Neoplasms Maintenance Chemotherapy Mutation Neoplasm Metastasis Neoplasm Staging Prognosis Treatment Outcome
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/178723
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-178723
record_format	dspace
spelling	sg-nus-scholar.10635-1787232023-10-31T21:58:10Z Meta-analysis of first-line therapies with maintenance regimens for advanced non-small-cell lung cancer (NSCLC) in molecularly and clinically selected populations Tan, P.S Bilger, M Lopes, G.L Acharyya, S Haaland, B DUKE-NUS MEDICAL SCHOOL afatinib antineoplastic agent bevacizumab cetuximab conatumumab epidermal growth factor receptor erlotinib gefitinib necitumumab pemetrexed antineoplastic agent tumor marker Article cancer combination chemotherapy cancer survival drug efficacy EGFR gene gene gene mutation histology human meta analysis non small cell lung cancer outcome assessment overall survival patient selection personalized medicine priority journal progression free survival squamous cell lung carcinoma survival analysis survival rate survival time Bayes theorem cancer staging genetics induction chemotherapy lung tumor maintenance chemotherapy metastasis mortality mutation non small cell lung cancer prognosis proto oncogene treatment outcome Antineoplastic Combined Chemotherapy Protocols Bayes Theorem Biomarkers, Tumor Carcinoma, Non-Small-Cell Lung Genes, erbB-1 Humans Induction Chemotherapy Lung Neoplasms Maintenance Chemotherapy Mutation Neoplasm Metastasis Neoplasm Staging Prognosis Treatment Outcome 10.1002/cam4.1101 Cancer Medicine 6 8 1847-1860 2020-10-21T08:07:47Z 2020-10-21T08:07:47Z 2017 Article Tan, P.S, Bilger, M, Lopes, G.L, Acharyya, S, Haaland, B (2017). Meta-analysis of first-line therapies with maintenance regimens for advanced non-small-cell lung cancer (NSCLC) in molecularly and clinically selected populations. Cancer Medicine 6 (8) : 1847-1860. ScholarBank@NUS Repository. https://doi.org/10.1002/cam4.1101 20457634 https://scholarbank.nus.edu.sg/handle/10635/178723 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	afatinib antineoplastic agent bevacizumab cetuximab conatumumab epidermal growth factor receptor erlotinib gefitinib necitumumab pemetrexed antineoplastic agent tumor marker Article cancer combination chemotherapy cancer survival drug efficacy EGFR gene gene gene mutation histology human meta analysis non small cell lung cancer outcome assessment overall survival patient selection personalized medicine priority journal progression free survival squamous cell lung carcinoma survival analysis survival rate survival time Bayes theorem cancer staging genetics induction chemotherapy lung tumor maintenance chemotherapy metastasis mortality mutation non small cell lung cancer prognosis proto oncogene treatment outcome Antineoplastic Combined Chemotherapy Protocols Bayes Theorem Biomarkers, Tumor Carcinoma, Non-Small-Cell Lung Genes, erbB-1 Humans Induction Chemotherapy Lung Neoplasms Maintenance Chemotherapy Mutation Neoplasm Metastasis Neoplasm Staging Prognosis Treatment Outcome
spellingShingle	afatinib antineoplastic agent bevacizumab cetuximab conatumumab epidermal growth factor receptor erlotinib gefitinib necitumumab pemetrexed antineoplastic agent tumor marker Article cancer combination chemotherapy cancer survival drug efficacy EGFR gene gene gene mutation histology human meta analysis non small cell lung cancer outcome assessment overall survival patient selection personalized medicine priority journal progression free survival squamous cell lung carcinoma survival analysis survival rate survival time Bayes theorem cancer staging genetics induction chemotherapy lung tumor maintenance chemotherapy metastasis mortality mutation non small cell lung cancer prognosis proto oncogene treatment outcome Antineoplastic Combined Chemotherapy Protocols Bayes Theorem Biomarkers, Tumor Carcinoma, Non-Small-Cell Lung Genes, erbB-1 Humans Induction Chemotherapy Lung Neoplasms Maintenance Chemotherapy Mutation Neoplasm Metastasis Neoplasm Staging Prognosis Treatment Outcome Tan, P.S Bilger, M Lopes, G.L Acharyya, S Haaland, B Meta-analysis of first-line therapies with maintenance regimens for advanced non-small-cell lung cancer (NSCLC) in molecularly and clinically selected populations
description	10.1002/cam4.1101
author2	DUKE-NUS MEDICAL SCHOOL
author_facet	DUKE-NUS MEDICAL SCHOOL Tan, P.S Bilger, M Lopes, G.L Acharyya, S Haaland, B
format	Article
author	Tan, P.S Bilger, M Lopes, G.L Acharyya, S Haaland, B
author_sort	Tan, P.S
title	Meta-analysis of first-line therapies with maintenance regimens for advanced non-small-cell lung cancer (NSCLC) in molecularly and clinically selected populations
title_short	Meta-analysis of first-line therapies with maintenance regimens for advanced non-small-cell lung cancer (NSCLC) in molecularly and clinically selected populations
title_full	Meta-analysis of first-line therapies with maintenance regimens for advanced non-small-cell lung cancer (NSCLC) in molecularly and clinically selected populations
title_fullStr	Meta-analysis of first-line therapies with maintenance regimens for advanced non-small-cell lung cancer (NSCLC) in molecularly and clinically selected populations
title_full_unstemmed	Meta-analysis of first-line therapies with maintenance regimens for advanced non-small-cell lung cancer (NSCLC) in molecularly and clinically selected populations
title_sort	meta-analysis of first-line therapies with maintenance regimens for advanced non-small-cell lung cancer (nsclc) in molecularly and clinically selected populations
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/178723
_version_	1781792307258851328

Meta-analysis of first-line therapies with maintenance regimens for advanced non-small-cell lung cancer (NSCLC) in molecularly and clinically selected populations

Similar Items